BPTH Bio-Path Holdings Inc

Price (delayed)

$1.725

Market cap

$2.86M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$26.11

Enterprise value

$2.75M

Bio-Path is a biotechnology company developing DNAbilizeĀ®, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion. Bio-Path's lead ...

Highlights
Bio-Path Holdings's debt has shrunk by 56% YoY and by 25% QoQ
Bio-Path Holdings's EPS has increased by 38% YoY and by 22% from the previous quarter
BPTH's equity has dropped by 129% year-on-year
The quick ratio has plunged by 99% YoY and by 91% from the previous quarter

Key stats

What are the main financial stats of BPTH
Market
Shares outstanding
1.66M
Market cap
$2.86M
Enterprise value
$2.75M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$13.96M
EBITDA
-$13.78M
Free cash flow
-$8.92M
Per share
EPS
-$26.11
Free cash flow per share
-$13.79
Book value per share
-$3.87
Revenue per share
$0
TBVPS
$2.73
Balance sheet
Total assets
$1.77M
Total liabilities
$4.39M
Debt
$85,000
Equity
-$2.63M
Working capital
-$2.18M
Liquidity
Debt to equity
-0.03
Current ratio
0.43
Quick ratio
0.05
Net debt/EBITDA
0.01
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-337.8%
Return on equity
-1,037.3%
Return on invested capital
-3,715.8%
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BPTH stock price

How has the Bio-Path Holdings stock price performed over time
Intraday
0.29%
1 week
-5.74%
1 month
-17.86%
1 year
81.98%
YTD
272.57%
QTD
-13.75%

Financial performance

How have Bio-Path Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.25M
Net income
-$13.96M
Gross margin
N/A
Net margin
N/A
BPTH's net income is up by 13% since the previous quarter and by 12% year-on-year
The operating income is up by 10% since the previous quarter and by 10% year-on-year

Growth

What is Bio-Path Holdings's growth rate over time

Valuation

What is Bio-Path Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Bio-Path Holdings's EPS has increased by 38% YoY and by 22% from the previous quarter
BPTH's equity has dropped by 129% year-on-year

Efficiency

How efficient is Bio-Path Holdings business performance
The return on equity has dropped by 176% since the previous quarter
BPTH's return on assets is down by 36% since the previous quarter

Dividends

What is BPTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BPTH.

Financial health

How did Bio-Path Holdings financials performed over time
The total assets is 60% less than the total liabilities
Bio-Path Holdings's total liabilities has surged by 120% YoY and by 58% QoQ
The quick ratio has plunged by 99% YoY and by 91% from the previous quarter
Bio-Path Holdings's debt is 103% higher than its equity
BPTH's equity has dropped by 129% year-on-year
The company's debt to equity has shrunk by 112% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.